Targeting #SRSF1 with TN2008 disrupts tumor cell metabolism and enhances CD8+ T cell #AntiTumorImmunity, improving glycolytic reprogramming, effector function, and adoptive #TCellTherapy efficacy. @fudan-university.bsky.social #medsky

#OpenAccess in #STTT: doi.org/10.1038/s413...